GGrantIndex
← Search

PN401 IN PATIENTS W/ PYRIMIDINE RESPONSIVE SYNDROME

$0M01FY2000RRNIH

University Of California San Diego, La Jolla CA

Investigators

Linked publications & trials

Abstract

Evaluate the safety and efficacy of PN401 in reducing seizures and infection, improvement of speech, language and cognitive functions in patients with pyrimidine responsive syndrome of neurological dysfunction and susceptibility to infection. Evaluate the quality of life and describe effects of PN401 on signs and symptoms of the syndrome.

View original record on NIH RePORTER →